Literature DB >> 33772066

Octanoic acid a major component of widely consumed medium-chain triglyceride ketogenic diet is detrimental to bone.

Shreshta Jain1, Reena Rai2, Divya Singh2, Divya Vohora3.   

Abstract

Octanoic acid is a medium-chained saturated fatty acid found abundantly in the ketogenic dietary supplements containing medium chained triglycerides (MCT) along with decanoic acid. The MCT ketogenic diet is commonly consumed for weight loss but has also showcased neuroprotective potential against neurodegenerative disorders. However, recent clinical findings have reported a critical disadvantage with the long-term consumption of ketogenic diet i.e. bone loss. The following study was employed to investigate whether the two major components of MCT diet also possess bone loss potential as observed with classical ketogenic diet. Swiss albino mice aged between 10 and 12 weeks, were divided into 3 treatment groups that were administered with oral suspensions of octanoic acid, decanoic acid and a combination of both for 4 weeks. Bone specific markers, microarchitectural parameters, using micro computed tomography, and biomechanical strength were analyzed. Remarkably deleterious alterations in the trabecular bone microarchitecture, and on bone markers were observed in the octanoic acid treated groups. Our results suggest significant negative effects on bone health by octanoic acid. These findings require further investigation and validation in order to provide significant clinically relevant data to possibly modify dietary composition of the MCT ketogenic diet.

Entities:  

Year:  2021        PMID: 33772066      PMCID: PMC7997977          DOI: 10.1038/s41598-021-86468-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  31 in total

1.  Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review.

Authors:  Thaninee Prasoppokakorn; Suda Jirasakuldej; Narisorn Lakananurak
Journal:  Eur J Clin Nutr       Date:  2019-07-17       Impact factor: 4.016

Review 2.  An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs.

Authors:  Barbara Miziak; Magdalena Chrościńska-Krawczyk; Stanisław J Czuczwar
Journal:  Expert Opin Drug Saf       Date:  2019-06-06       Impact factor: 4.250

3.  Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.

Authors:  Wen-Cheng Huang; Tsung-Hsien Tsai; Lu-Te Chuang; You-Yi Li; Christos C Zouboulis; Po-Jung Tsai
Journal:  J Dermatol Sci       Date:  2013-11-07       Impact factor: 4.563

4.  A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy.

Authors:  Elizabeth G Neal; Hannah Chaffe; Ruby H Schwartz; Margaret S Lawson; Nicole Edwards; Georgiana Fitzsimmons; Andrea Whitney; J Helen Cross
Journal:  Epilepsia       Date:  2008-11-19       Impact factor: 5.864

5.  The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up.

Authors:  Danielle A J E Lambrechts; Reina J A de Kinderen; Hans S H Vles; Anton J de Louw; Albert P Aldenkamp; Marian J M Majoie
Journal:  Epilepsy Behav       Date:  2015-08-24       Impact factor: 2.937

6.  The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats.

Authors:  Yan Zhao; Bing Zou; Zhenyu Shi; Qiong Wu; Guo-Qiang Chen
Journal:  Biomaterials       Date:  2007-03-14       Impact factor: 12.479

7.  Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil.

Authors:  Marie-Pierre St-Onge; Aubrey Bosarge
Journal:  Am J Clin Nutr       Date:  2008-03       Impact factor: 7.045

8.  Marked Seizure Reduction after MCT Supplementation.

Authors:  Raed Azzam; Nabil J Azar
Journal:  Case Rep Neurol Med       Date:  2013-12-08

Review 9.  A simple practice guide for dose conversion between animals and human.

Authors:  Anroop B Nair; Shery Jacob
Journal:  J Basic Clin Pharm       Date:  2016-03

Review 10.  Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders.

Authors:  Katrin Augustin; Aziza Khabbush; Sophie Williams; Simon Eaton; Michael Orford; J Helen Cross; Simon J R Heales; Matthew C Walker; Robin S B Williams
Journal:  Lancet Neurol       Date:  2017-12-16       Impact factor: 44.182

View more
  2 in total

1.  Oral Palatability Testing of a Medium-Chain Triglyceride Oil Supplement (MCT) in a Cohort of Healthy Dogs in a Non-Clinical Setting.

Authors:  Benjamin Andreas Berk; Rowena Mary-Anne Packer; Julia Fritz; Holger Andreas Volk
Journal:  Animals (Basel)       Date:  2022-06-26       Impact factor: 3.231

Review 2.  Obesity, Bone Loss, and Periodontitis: The Interlink.

Authors:  Pengfei Zhao; Aimin Xu; Wai Keung Leung
Journal:  Biomolecules       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.